Parabilis Medicines, a clinical-stage biopharmaceutical company, appointed Fawzi Benzaghou, M.D., as the company’s Chief Medical Officer. Benzaghou is a seasoned oncology leader with deep industry and regulatory experience spanning all stages of global drug development, from early-stage discovery and clinical development through regulatory approval and commercialization. As the company’s Chief Medical Officer, Benzaghou will shape the overall clinical and regulatory strategy and operations fo...